Antifungals In Eye Infections: Drugs And Routes Of Administration

1Post-graduation Programme in Ophthalmic Medical Sciences, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas/ SP, Brazil. 2Department of Ophthalmology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas/SP, Brazil. Institution: Work conducted at the University Hospital of the State University of Campinas (UNICAMP), Campinas/SP, Brazil. ABSTRACT

• Publication year

  2013

• Venue

  Scopus

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1590/S0034-72802013000200014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Econazole: A Review of its Antifungal Activity and Therapeutic Efficacy

  2012cited by this paper
• Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series

  2011cited by this paper
• The Effects of Intrastromal Voriconazole Injection and Topical Voriconazole in the Treatment of Recalcitrant Fusarium Keratitis

  2011cited by this paper
• Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis

  2010cited by this paper
• Topical Amphotericin B and Subconjunctival Injection of Fluconazole (Combination Therapy) Versus Topical Amphotericin B (Monotherapy) in Treatment of Keratomycosis

  2010cited by this paper
• Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation.

  2010cited by this paper
• The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis

  2010cited by this paper
• Comparison of natamycin and voriconazole for the treatment of fungal keratitis.

  2010influential reference
• Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis

  2010cited by this paper
• Corneal and Aqueous Humor Concentrations of Amphotericin B Using Three Different Routes of Administration in a Rabbit Model

  2009cited by this paper
• Topical and Oral Voriconazole in the Treatment of Fungal Keratitis

  2009cited by this paper
• In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.

  2009influential reference
• Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials.

  2008cited by this paper
• Effect of topical 0.5% povidone-iodine compared to 5% natamycin in fungal keratitis caused by Fusarium solani in a rabbit model: a pilot study.

  2008cited by this paper
• Development of Effective Ocular Preparations of Antifungal Agents

  2008influential reference
• Preparation and Stability of Voriconazole Eye Drop Solution

  2008cited by this paper
• Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis.

  2008cited by this paper
• In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.

  2008influential reference
• Ketoconazole- and fluconazole-induced embryotoxicity and skeletal anomalies in wistar rats: a comparative study

  2008influential reference
• Voriconazole in the treatment of fungal eye infections: a review of current literature

  2008cited by this paper
• Miconazole Induces Changes in Actin Cytoskeleton prior to Reactive Oxygen Species Induction in Yeast*

  2007cited by this paper
• Ocular fungal isolates and antifungal susceptibility in northern China.

  2007cited by this paper
• Efficacy of Intracameral Amphotericin B Injection in the Management of Refractory Keratomycosis and Endophthalmitis

  2007cited by this paper
• Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.

  2007influential reference
• Therapeutic Effect of Intracameral Amphotericin B Injection in the Treatment of Fungal Keratitis

  2007cited by this paper
• Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592).

  2007cited by this paper
• Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

  2006influential reference
• Echinocandins in the management of invasive fungal infections, Part 2.

  2006cited by this paper
• Echinocandins in the management of invasive fungal infections, part 1.

  2006cited by this paper
• Use of oral voriconazole as adjunctive treatment of severe cornea fungal infection: case report.

  2006cited by this paper
• Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.

  2006cited by this paper
• The Postantifungal Effect (PAFE) of Itraconazole, in Comparison with Those of Miconazole and Fluconazole, on Candida Species

  2006cited by this paper
• The Echinocandins: Comparison of Their Pharmacokinetics, Pharmacodynamics and Clinical Applications

  2006cited by this paper
• Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection

  2006cited by this paper
• Atualização no uso de agentes antifúngicos

  2006influential reference
• [Fungal keratitis in an intertropical area: diagnosis and treatment problems. Advantage of local use of polyvidone iodine].

  2006cited by this paper
• Voriconazole and Fungal Keratitis: A Report of Two Treatment Failures

  2006cited by this paper
• Eficiência terapêutica das formulações lipídicas de anfotericina B

  2006cited by this paper
• Miconazole: a historical perspective

  2006cited by this paper
• Topical Caspofungin for Treatment of Keratitis Caused by Candida albicans in a Rabbit Model

  2005cited by this paper
• Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.

  2005cited by this paper
• Successful Topical Application of a New Antifungal Agent, Micafungin, in the Treatment of Refractory Fungal Corneal Ulcers: Report of Three Cases and Literature Review

  2005cited by this paper
• Severe fungal keratitis treated with subconjunctival fluconazole.

  2005cited by this paper
• Comparison of Topical Itraconazole 1% With Topical Natamycin 5% for the Treatment of Filamentous Fungal Keratitis

  2005cited by this paper
• Posaconazole: a broad-spectrum triazole antifungal.

  2005cited by this paper
• Interaction between Posaconazole and Amphotericin B in Concomitant Treatment against Candida albicans In Vivo

  2005cited by this paper
• Clinical experience in managing Fusarium solani keratitis

  2005cited by this paper
• Intracorneal injection of amphothericin B for recurrent fungal keratitis and endophthalmitis.

  2005cited by this paper
• Activity of Posaconazole Combined with Amphotericin B against Aspergillus flavus Infection in Mice: Comparative Studies in Two Laboratories

  2004cited by this paper
• In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.

  2004cited by this paper
• Fungal Keratitis Caused by Paecilomyces lilacinus Associated With a Retained Intracorneal Hair

  2004cited by this paper
• Toxicity and efficacy of intravitreal injection of spartanamicin B* in the treatment of Candida endophthalmitis **

  2004cited by this paper
• Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.

  2004cited by this paper
• In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature

  2004cited by this paper
• Effect of voriconazole on a corneal abscess caused by fusarium.

  2004cited by this paper
• Advanced Fusarium Keratitis Progressing to Endophthalmitis

  2003cited by this paper
• Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis

  2003cited by this paper
• Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.

  2003cited by this paper
• Keratitis Caused by Scedosporium apiospermum Successfully Treated with a Cornea Transplant and Voriconazole

  2003cited by this paper
• Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi

  2003cited by this paper
• Antifungal susceptibility testing of yeast isolated from corneal infections

  2003cited by this paper
• Voriconazole: A New Triazole Antifungal Agent

  2003cited by this paper
• Current Perspectives on Ophthalmic Mycoses

  2003cited by this paper
• A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis

  2003cited by this paper
• Intracameral Amphotericin B Injection in the Management of Deep Keratomycosis

  2002cited by this paper
• In Vitro Activity of Caspofungin against Candida albicans Biofilms

  2002cited by this paper
• Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

  2002cited by this paper
• Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect

  2002cited by this paper
• Comparison of caspofungin and amphotericin B for invasive candidiasis.

  2002cited by this paper
• Do climatic variables influence the development of posterior vitreous detachment?

  2002cited by this paper
• Intracameral Amphotericin B: Initial Experience in Severe Keratomycosis

  2001cited by this paper
• Update on Antifungal Agents

  2001cited by this paper
• Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.

  2000cited by this paper
• Isolated post-operative Aspergillus niger endophthalmitis

  2000cited by this paper
• Treatment of Postkeratitis Fusarium Endophthalmitis with Amphotericin B Lipid Complex

  2000cited by this paper
• Spectrum of Fungal Keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania

  2000cited by this paper
• Safety evaluation of certain food additives and contaminants

  2000cited by this paper
• Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.

  1998cited by this paper
• Fungal Keratitis

  1998cited by this paper
• Miconazole‐Induced Fatal Dysrhythmia

  1997cited by this paper
• Mycotic Keratitis in Children: Epidemiologic and Microbiologic Evaluation

  1997cited by this paper
• Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosis.

  1997cited by this paper
• Ocular penetration and pharmacokinetics of topical fluconazole.

  1997cited by this paper
• Treatment of fungal corneal ulcers with amphotericin B ointment.

  1997cited by this paper
• Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis.

  1996cited by this paper
• Candida albicans keratitis treated successfully with itraconazole.

  1996cited by this paper
• Use of amphotericin B with azole antifungal drugs: what are we doing?

  1995cited by this paper
• [Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B].

  1995cited by this paper
• Fluconazole in the management of fungal ocular infections.

  1994cited by this paper
• The changing spectrum of fungal keratitis in south Florida.

  1994cited by this paper
• Administering amphotericin B--a practical approach.

  1994cited by this paper
• Oral fluconazole therapy for keratomycosis

  1994cited by this paper
• Influence of corticosteroid on experimentally induced keratomycosis.

  1991cited by this paper
• Differences in response in vivo to amphotericin B among Candida albicans strains.

  1991cited by this paper
• Ocular uptake of fluconazole following oral administration.

  1990cited by this paper
• Medical and Surgical Treatment

  1990cited by this paper
• Amphotericin B: 30 years of clinical experience.

  1990cited by this paper
• Clinical and experimental mycotic corneal ulcer caused by Aspergillus fumigatus and the effect of oral ketoconazole in the treatment

  1989cited by this paper
• Management of human keratomycosis with miconazole.

  1989cited by this paper
• Oral ketoconazole in Keratomycosis.

  1987cited by this paper

• Ultrastructural and Immunohistochemical Study of Double and Combined Intravitreal Administration of Antifungal Agents in the Retina of New Zealand Albino Rabbits: An Experimental Protocol

  2025cites this paper
• Rosemary Essential Oil Microemulsion for Fungal Keratitis Treatment

  2025cites this paper
• Elevating Therapeutic Potential: Levofloxacin-Loaded Ocular Films for Conjunctivitis Management

  2024cites this paper
• Synergistic activity of clioquinol with voriconazole and amphotericin B against fungi of interest in eye infections.

  2024cites this paper
• Intrastromal voriconazole as successful adjunctive approach for recalcitrant deep fungal keratitis

  2023cites this paper
• Complications of intravitreal injections: 2022

  2022cites this paper
• Cyclodextrin-based Pickering nanoemulsions containing amphotericin B: Part I. evaluation of oil/cyclodextrin and amphotericin B/cyclodextrin inclusion complexes

  2022cites this paper
• Optimal Design of Novel Microemulsions-Based Two-Layered Dissolving Microneedles for Delivering Fluconazole in Treatment of Fungal Eye Infection

  2022cites this paper
• Effectiveness of Voriconazole in Treating Fungal Keratitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2022cites this paper
• Novel Drug Delivery Systems to Improve the Treatment of Keratitis

  2022cites this paper
• An Atypical Etiology of Fungal Keratitis Caused by Roussoella neopustulans

  2022cites this paper
• Challenging case of treating fungal keratitis

  2022influential citation
• Lactones: Classification, synthesis, biological activities, and industrial applications

  2021cites this paper
• Fusarium Keratitis—Review of Current Treatment Possibilities

  2021cites this paper
• Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies

  2021cites this paper
• Journal of Medical Microbiology and Tropical Diseases

  2021cites this paper
• Nanocubosomal based in situ gel loaded with natamycin for ocular fungal diseases: development, optimization, in-vitro, and in-vivo assessment

  2021cites this paper
• High-Dose Oral Posaconazole for the Treatment of Recalcitrant Fungal Keratitis

  2021cites this paper
• Ocular toxicity assessment of nanoemulsion in-situ gel formulation of fluconazole

  2021cites this paper
• Treatment of Recalcitrant Mycotic Keratouveitis with Targeted Voriconazole Injection Combined with Hypopyon Drainage

  2021cites this paper
• Ηistological Effects of Intravitreal Injection of Voriconazole and Micafungin: A Review

  2021influential citation
• Evaluating Potential of Electromagnetic Microwaves on Destruction Acanthamoeba Cysts

  2020cites this paper
• Carboxyvinyl Polymer and Guar-Borate Gelling System Containing Natamycin Loaded PEGylated Nanolipid Carriers Exhibit Improved Ocular Pharmacokinetic Parameters

  2020cites this paper
• Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: improved pharmacokinetic/pharmacodynamic properties.

  2020cites this paper
• Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit

  2020cites this paper
• Voriconazole Induced Ocular Surface Dysplasia – Report of Two Cases

  2020cites this paper
• Histological Effects of Intravitreal Injection of Antifungal Agents in New Zealand White Rabbits: An Electron Microscopic and Immunohistochemical Study

  2020influential citation
• A new storage medium containing amphotericin B versus Optisol-GS for preservation of human donor corneas

  2020cites this paper
• Fungal keratitis management in a referral cornea center in Brazil

  2020influential citation
• Infectious Keratitis: The Great Enemy

  2019cites this paper
• Intrastromal voriconazole: An adjuvant approach for recalcitrant mycotic keratitis

  2019cites this paper
• MITIGATION APPROACH TO AVOID FUNGAL COLONISATION OF POROUS LIMESTONE

  2019cites this paper
• Evaluation of Liposomal and Conventional Amphotericin B in Experimental Fungal Keratitis Rabbit Model

  2019cites this paper
• Natamycin solid lipid nanoparticles – sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization

  2019cites this paper
• Evolving nanotechnological trends in the management of mycotic keratitis

  2019cites this paper
• Pharmacologic therapy of mycotic keratitis.

  2019cites this paper
• Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections

  2019cites this paper
• Conjunctiva Necrosis Following Subconjunctival Amphotericin B Injection in Fungal Keratitis

  2019cites this paper
• Recent advances in topical nano drug-delivery systems for the anterior ocular segment.

  2018cites this paper
• Optimization of &bgr;‐cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug

  2018cites this paper
• PREPARATION AND CHARACTERIZATION OF ECONAZOLE NITRATE INCLUSION COMPLEX FOR OCULAR DELIVERY SYSTEM

  2018cites this paper
• Effect of itraconazole on the cornea in a murine suture model and penetrating keratoplasty model.

  2017cites this paper
• Echinocandins in Ocular Therapeutics

  2017cites this paper
• Potential of novel drug delivery systems in the management of topical candidiasis

  2017cites this paper
• Current perspectives on natamycin in ocular fungal infections

  2017cites this paper
• Effect of Three Medicinal Plants Extracts on the Growth of Some Yeasts

  2017cites this paper
• Corneal Fungal Keratomycosis-A Therapeutic Challenge : A Case Report

  2017cites this paper
• Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial

  2017cites this paper
• Antifungal Therapy in Eye Infections: New Drugs, New Trends

  2016cites this paper
• Availability of antifungal eye drops in hospital and private retail pharmacies: a survey conducted in Kumasi, Ghana -

  2016cites this paper
• Recent advances in diagnosis and management of Mycotic Keratitis

  2016cites this paper
• Candida parapsilosis keratitis treated successfully with topical and oral fluconazole

  2016cites this paper
• Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses

  2015cites this paper
• Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole.

  2015cites this paper